Catherine Joran-Lebrun

Title: Catherine Joran-Lebrun: Innovator in Pharmaceutical Chemistry

Introduction

Catherine Joran-Lebrun is a notable inventor based in Contamine-Sarzin, France. She has made significant contributions to the field of pharmaceutical chemistry, particularly through her innovative work on sulfanilide derivatives. Her research focuses on developing compounds that have potential therapeutic applications in various medical conditions.

Latest Patents

Catherine holds a patent for "Pharmaceutically active sulfanilide derivatives." This invention relates to sulfanilide derivatives of a specific formula, which are designed for use as pharmaceutically active compounds. These derivatives are particularly useful in treating and preventing conditions such as preterm labor, premature birth, dysmenorrhea, and other serious health issues. The compounds exhibit substantial modulatory activity on oxytocin and vasopressin receptors, making them valuable in addressing disease states mediated by these hormones.

Career Highlights

Catherine is associated with Laboratoires Serono S.A., where she applies her expertise in pharmaceutical research. Her work has led to advancements in the development of new therapeutic agents, showcasing her commitment to improving healthcare outcomes.

Collaborations

Catherine has collaborated with notable colleagues, including Dennis Church and Matthias Schwarz. These partnerships have contributed to her innovative research and the successful development of her patented compounds.

Conclusion

Catherine Joran-Lebrun is a pioneering inventor whose work in pharmaceutical chemistry has the potential to impact various medical fields significantly. Her dedication to innovation and collaboration continues to drive advancements in healthcare.